267 research outputs found

    Evaluating Amazon\u27s Mechanical Turk as a Tool for Experimental Behavioral Research

    Full text link
    Amazon Mechanical Turk (AMT) is an online crowdsourcing service where anonymous online workers complete web-based tasks for small sums of money. The service has attracted attention from experimental psychologists interested in gathering human subject data more efficiently. However, relative to traditional laboratory studies, many aspects of the testing environment are not under the experimenter\u27s control. In this paper, we attempt to empirically evaluate the fidelity of the AMT system for use in cognitive behavioral experiments. These types of experiment differ from simple surveys in that they require multiple trials, sustained attention from participants, comprehension of complex instructions, and millisecond accuracy for response recording and stimulus presentation. We replicate a diverse body of tasks from experimental psychology including the Stroop, Switching, Flanker, Simon, Posner Cuing, attentional blink, subliminal priming, and category learning tasks using participants recruited using AMT. While most of replications were qualitatively successful and validated the approach of collecting data anonymously online using a web-browser, others revealed disparity between laboratory results and online results. A number of important lessons were encountered in the process of conducting these replications that should be of value to other researchers

    The Use of Near Infrared and Microwave Sensing for On-line Real Time Monitoring of Moisture Content and Composition of Powder Blend

    Get PDF
    Online process analytics has been a topic of interest by pharmaceutical companies as a method of determining how operating parameters affect the final quality of their products. One form of online process analytics that has been found to be effective is microwave sensing. While it has been found that microwave resonance sensing can be used to measure parameters such as moisture content and density, it has yet to be discovered if such sensors have the ability to measure changes in content uniformity of raw materials pharmaceutical companies use. Data was collected using a spin riffler fitted with a microwave sensor and a near infrared probe (NIR) (more commonly used method of monitoring) that is to be tested against. Various known compositions mixtures of acetaminophen (APAP) and microcrystalline cellulose (MCC) powders were created and tested for content uniformity and moisture content by passing it over the sensor. The raw data was passed through MATLAB’s neural networks software and a calibration model was created for content uniformity that can be used to predict values. Upon analyzing the data, it was found that an accurate reading of composition uniformity could be determined using a microwave sensor. The model created aided in determining the composition of unknown blends of powder and proved to be accurate. This calibration model will serve as a contribution to the ongoing research being performed in online process analytics. By utilizing these techniques, pharmaceutical companies have the ability to more efficiently analyze their products in an online real-time process

    Learning Categories From an Intermittent Teacher

    Full text link

    Effect of supplementation with n-3 polyunsaturated fatty acids and/or β-glucans on performance, feeding behaviour and immune status of Holstein Friesian bull calves during the pre- and post-weaning periods

    Get PDF
    peer-reviewedBackground Previous research in both calves and other species has suggested n-3 polyunsaturated fatty acids (PUFA) and β-glucans may have positive effects on immune function. This experiment measured performance, behaviour, metabolite and immunological responses to pre-weaning supplementation of dairy bull calves with n-3 PUFA in the form of fish oil and β-glucans derived from seaweed extract. 44 Holstein Friesian bull calves, aged 13.7 ± 2.5 d and weighing 48.0 ± 5.8 kg were artificially reared using an electronic feeding system. Each calf was offered 5 L (120 g/L) per day of milk replacer (MR) and assigned to one of four treatments included in the MR, (1) Control (CON); (2) 40 g n-3 PUFA per day (FO); (3) 1 g β-glucans per day (GL) and (4) 40 g n-3 PUFA per day & 1 g/d β-glucans (FOGL) in a 2 × 2 factorial design. Milk replacer and concentrate was offered from d 0–62 (pre-weaning), while concentrate provision continued for a further 31 d post-weaning period. Individual daily feed intake and feeding behaviour was recorded throughout, while bodyweight and blood analyte data were collected at regular intervals. Results Overall mean concentrate DMI from d 0–93 was 1.39, 1.27, 1.00 and 0.72 kg/d for CON, FO, GL and FOGL calves, respectively (SEM = 0.037; P < 0.0001). Calves supplemented with GL were significantly lighter (P < 0.0001) at both weaning (d 62) and turnout to pasture (d 93) than un-supplemented calves, with a similar effect (P < 0.0001) evident for calves receiving FO compared to un-supplemented contemporaries. Supplementation with GL reduced the number of unrewarded visits where milk was not consumed (P < 0.0001) while supplementation with FO increased mean drinking speed (P < 0.0001). Supplementation with GL resulted in greater concentrations of haptoglobin (P = 0.034), greater serum osmolality (P = 0.021) and lower lymphocyte levels (P = 0.027). In addition, cells from GL supplemented calves exhibited a lower response than un-supplemented contemporaries to both Phytohaemagglutinin A stimulated IFN-γ (P = 0.019) and Concanavalin A stimulated IFN-γ (P = 0.012) following in vitro challenges. Conclusions Pre-weaning supplementation of bull calves with either n-3 PUFA or β-glucan resulted in reduced voluntary feed intake of concentrate and consequently poorer pre-weaning calf performance. There was no evidence for any beneficial effect of either supplementation strategy on calves’ immune responses

    The formation of Encke meteoroids and dust trail

    Full text link
    We observed comet 2P/Encke with the Infrared Space Observatory ISOCAM on July 14, 1997 from a particularly favorable viewing geometry above the comet's orbital plane and at a distance of 0.25 AU. A structured coma was observed, along with a long, straight dust trail. For the first time, we are able to observe the path of particles as they evolve from the nucleus to the trail. The particles that produce the infrared coma are large, with a radiation to gravitational force ratio betamm-sized particles). The dust trail follows the orbit of the comet across our image, with a central core that is 20,000 km wide, composed of particles with beta<1e-5 (size 5\sim 5 cm) from previous apparitions. The abundant large particles near the comet pose a significant hazard to spacecraft. There is no evidence of a classical cometary dust tail due to small particles with beta>0.001, in marked contrast to other comets like P/Halley or C/Hale-Bopp. The structure of the coma requires anisotropic emission and that the spin axis of the nucleus to be nearly parallel to the orbital plane, resulting in strong seasonal variations of the particle emission. While most of the infrared coma emission is due to dust produced during the 1997 apparition, the core of the dust trail requires emissions from previous apparitions. The total mass lost during the 1997 apparition is estimated to be 2-6e13 g. Comparing to the gas mass loss from ultraviolet observations, the dust-to-gas mass ratio is 10-30, much higher than has ever been suggested from visual light observations. Using the recently-measured nuclear diameter, we find that Encke can only last 3000-10,000 rhoN yr (where rhoN is the nuclear density in g/cc) at its present mass loss rate.Comment: manuscript in TeX, 10 figures (6 ps, 4 jpg); accepted by Icarus July 3, 200

    Variability of Disk Emission in Pre-Main Sequence and Related Stars. I. HD 31648 and HD 163296 - Isolated Herbig Ae Stars Driving Herbig-Haro Flows

    Get PDF
    Infrared photometry and spectroscopy covering a time span of a quarter century are presented for HD 31648 (MWC 480) and HD 163296 (MWC 275). Both are isolated Herbig Ae stars that exhibit signs of active accretion, including driving bipolar flows with embedded Herbig-Haro (HH) objects. HD 163296 was found to be relatively quiescent photometrically in its inner disk region, with the exception of a major increase in emitted flux in a broad wavelength region centered near 3 microns in 2002. In contrast, HD 31648 has exhibited sporadic changes in the entire 3-13 micron region throughout this span of time. In both stars the changes in the 1-5 micron flux indicate structural changes in the region of the disk near the dust sublimation zone, possibly causing its distance from the star to vary with time. Repeated thermal cycling through this region will result in the preferential survival of large grains, and an increase in the degree of crystallinity. The variability observed in these objects has important consequences for the interpretation of other types of observations. For example, source variability will compromise models based on interferometry measurements unless the interferometry observations are accompanied by nearly-simultaneous photometric data.Comment: 55 pages, 18 figures, 2 tables, Accepted by Ap

    An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Opioid analgesics have proven efficacy in the short-term management of chronic cancer pain, but data on their long-term use is more limited. OROS<sup>® </sup>hydromorphone is a controlled-release formulation of oral hydromorphone that may be particularly well suited to long-term management of chronic cancer pain because it provides stable plasma concentrations and consistent analgesia with convenient once-daily dosing. The objective of this study (DO-118X) was to characterise the pain control achieved with long-term repeated dosing of OROS<sup>® </sup>hydromorphone in patients with chronic cancer pain.</p> <p>Methods</p> <p>In this multicentre, phase III, open-label, single treatment, 1-year extension study, OROS<sup>® </sup>hydromorphone was administered to 68 patients with moderate-to-severe chronic cancer pain, who had successfully completed a short-term equivalence study, and whose pain was controlled with a stable dose of medication (≥ 8 mg OROS<sup>® </sup>hydromorphone or equivalent controlled-release morphine). Patients were started on the dose of OROS<sup>® </sup>hydromorphone equivalent to the opioid dose on which they achieved dose-stable pain control in the equivalence study; dose adjustments were made as necessary and breakthrough pain medication was permitted. Efficacy was assessed with the Brief Pain Inventory (BPI) and patient and investigator global evaluations of treatment effectiveness. No formal statistical analysis was done.</p> <p>Results</p> <p>The mean (standard deviation) duration of exposure to study medication was 139 (129.9) days and the mean (standard deviation) average daily consumption of OROS<sup>® </sup>hydromorphone was 43.7 (28.14) mg/day. All scores were maintained at a mild to moderate severity throughout the study; however, BPI scores for pain at its worst, pain at its least, pain on average, pain right now, and pain relief were slightly worsened at end point compared with baseline. Mean BPI pain interference with daily activities and patient and investigator global evaluation scores also remained generally stable. Treatment effectiveness was rated as fair to good throughout the study. The most frequently reported adverse events were nausea (n = 24, 35.3%), constipation (n = 22, 32.4%), and vomiting (n = 15, 22.1%).</p> <p>Conclusion</p> <p>The results of this extension study suggest that long-term repeated dosing with once-daily OROS<sup>® </sup>hydromorphone can be beneficial in the continuing management of persistent, moderate-to-severe cancer pain.</p

    A novel ESR2 frameshift mutation predisposes to medullary thyroid carcinoma and causes inappropriate RET expression

    Get PDF
    corecore